Alligator Bioscience AB

- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2000-01-01
- Employees
- 58
- Market Cap
- -
Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Safety and Efficacy of Mitazalimab in Combination with Chemotherapy in Pancreatic Cancer Patients
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- Interventions
- Biological: CD40 agonist mitazalimab in combination with chemotherapy
- First Posted Date
- 2021-05-17
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Alligator Bioscience AB
- Target Recruit Count
- 94
- Registration Number
- NCT04888312
- Locations
- 🇧🇪
Cliniques Universitaires St-Luc, Brussels, Belgium
🇧🇪Hospital Erasme, Bruxelles, Belgium
🇧🇪UZA Antwerp, Edegem, Belgium
Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017
- Conditions
- Solid TumorNeoplasms
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2023-04-24
- Lead Sponsor
- Alligator Bioscience AB
- Target Recruit Count
- 27
- Registration Number
- NCT04144842
- Locations
- 🇸🇪
Department of Oncology, Skåne University Hospital, Lund, Sweden
🇸🇪Fas 1-enheten, Centrum för Kliniska Cancerstudier, Karolinska Universitetssjukhuset, Solna, Sweden
🇸🇪Department of Oncology, Uppsala University Hospital, Uppsala, Sweden
Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015
- Conditions
- Solid TumorNeoplasms
- First Posted Date
- 2018-12-20
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Alligator Bioscience AB
- Target Recruit Count
- 33
- Registration Number
- NCT03782467
- Locations
- 🇩🇰
Phase 1 Unit, Department of Oncology, Rigshospitalet, Copenhagen, Denmark
🇩🇰Center for Cancer Research, Department of Oncology, Herlev Hospital, Herlev, Denmark
🇸🇪Kliniska Prövningsenheten, Kliniska Studier Sverige - Forum Söder, Skånes Universitetssjukhus, Lund, Sweden
ADC-1013 First-in-Human Study
- Conditions
- NeoplasmsSolid Tumors
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Alligator Bioscience AB
- Target Recruit Count
- 24
- Registration Number
- NCT02379741
- Locations
- 🇩🇰
Center for Cancer Research, Department of Oncology, Herlev Hospital, Herlev, Denmark
🇸🇪Kliniska prövningsenheten (KPE), Karolinska University Hospital, Solna, Stockholm, Sweden
🇸🇪Department of Oncology, Uppsala University Hospital, Uppsala, Sweden